Nestlé is actively working on sarcopenia, the effects of which can be reduced through nutrition. An innovative product for which Artialis will conduct an in-depth clinical study that could result in an effective dietary supplement. To reach the targeted population of this study, Artialis chose to trust Dim3 as their partner for this major project.
Thanks to this application, Artialis will save considerable time in the clinical study, and of course money. For Jean-Claude Havaux, Dim3 CEO, this type of partnership between companies is a new model that should be duplicated as much as possible. “Hospitals no longer have the time or the money to do very sophisticated research. Co-creation between related companies makes it possible to remedy this”.